Effects of GLP-1RAs on Appetite, Satiety and Hunger, and Gastric Emptying GLP-1RAs are attractive agents for the management of obesity owing to the actions of GLP-1 on appetite and energy intake
Blood pressure falls, triglycerides improve, HDL rises, inflammation markers decrease, and the inflammatory adipose tissue that drives atherosclerosis shrinks
Post-marketing surveillance and patient reports continue to inform our understanding of medication side effects
In one episode, Bubble Bass considers a 'light snack' to be a big bucket of Krabby Patties, three large orders of fries, a hot dog and a large soda
The third consideration is risk management and longterm outcomes
A robust pipeline of oral GLP-1 agents and next-generation therapies with complementary mechanisms is advancing swiftly, intensifying competition and expanding future treatment possibilities